First Time Loading...

Nanalysis Scientific Corp
XTSX:NSCI

Watchlist Manager
Nanalysis Scientific Corp Logo
Nanalysis Scientific Corp
XTSX:NSCI
Watchlist
Price: 0.465 CAD 5.68%
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

NSCI Price Targets Summary
Nanalysis Scientific Corp

Wall Street analysts forecast NSCI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NSCI is 1.224 CAD with a low forecast of 1.212 CAD and a high forecast of 1.26 CAD.

NSCI Lowest Forecast
Wall Street Target
1.212 CAD
161% Upside
NSCI Average Forecast
Wall Street Target
1.224 CAD
163% Upside
NSCI Highest Forecast
Wall Street Target
1.26 CAD
171% Upside
Lowest
Price Target
1.212 CAD
161% Upside
Average
Price Target
1.224 CAD
163% Upside
Highest
Price Target
1.26 CAD
171% Upside
Nanalysis Scientific Corp Competitors:
Price Targets
BIM
Biomerieux SA
17% Upside
STXS
Stereotaxis Inc
102% Upside
PODD
Insulet Corp
37% Upside
ZBH
Zimmer Biomet Holdings Inc
16% Upside
BIM
Biomerieux SA
17% Upside
STXS
Stereotaxis Inc
102% Upside
PODD
Insulet Corp
37% Upside
ZBH
Zimmer Biomet Holdings Inc
16% Upside
SRDX
Surmodics Inc
88% Upside
PRN
Profound Medical Corp
63% Upside
002901
Double Medical Technology Inc
52% Upside
V
043150
Value Added Technology Co Ltd
43% Upside

Revenue
Forecast

Revenue Estimate
Nanalysis Scientific Corp

For the last 5 years the compound annual growth rate for Nanalysis Scientific Corp's revenue is 26%. The projected CAGR for the next 2 years is 18%.

26%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Nanalysis Scientific Corp

Operating Income forecast
is not available for
Nanalysis Scientific Corp

Net Income
Forecast

Net Income Estimate
Nanalysis Scientific Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
NSCI intrinsic value, competitors valuation, and company profile.
DCF Valuation
NSCI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NSCI stock valuation using valuation multiples.
Wall Street Estimates
NSCI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NSCI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NSCI's stock price target?
Price Target
1.224 CAD

According to Wall Street analysts, the average 1-year price target for NSCI is 1.224 CAD with a low forecast of 1.212 CAD and a high forecast of 1.26 CAD.

What is Nanalysis Scientific Corp's Revenue forecast?
Projected CAGR
18%

For the last 5 years the compound annual growth rate for Nanalysis Scientific Corp's revenue is 26%. The projected CAGR for the next 2 years is 18%.

ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.